Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in a calcium channel blocker

Archives Internationales de Pharmacodynamie et de Therapie

Volumn 331, Issue 3, 1996, Pages 246-262

  Bui Xuan, B ^a   Aupetit, J F ^a   Freysz, M ^a   Loufoua Moundanga, J ^a   Faucon, G ^a   Timour, Q ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; FLECAINIDE; SODIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SWINE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; FLECAINIDE; HEART; MYOCARDIAL ISCHEMIA; SODIUM CHANNEL BLOCKERS; SWINE; VENTRICULAR FIBRILLATION; VERAPAMIL;

EID: 0030459386     PISSN: 00039780     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ANDERSON, J. L., STEWART, J. R., PERRY, B. A., VAN HAMERSVELD, D. D., JOHNSTON, T. A., CONARD, G. J., CHANG, S. F., KVAM, D. C. and PITT, B. Oral flecainide acetate for the treatment of ventricular arrhythmias. New Engl. J. Med. 305, 473-476 (1981).
2. AUPETIT, J. F., TIMOUR, Q., CHEVREL, G., LOUFOUA-MOUNDANGA, J., OMAR, S. and FAUCON, G. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 509-514 (1993a).
3. AUPETIT, J. F., TIMOUR, Q., LARBRE, J. P., LOUFOUA-MOUNDANGA, J., KIOUECH, I., LOPEZ, M. and FAUCON, G. Arrhythmogenicity of Ic antiarrhythmic drugs and intraventricular conduction disorders: Possible aggravation by myocardial ischaemia. Study in the porcine in situ heart. Cardiovasc. Drugs Ther. 7, 217-223 (1993b).
4. AUPETIT, J. F., TIMOUR, Q., LOUFOUA-MOUNDANGA, J., BARRAL-CADIÈRE, L., LOPEZ, M., FREYSZ, M. and FAUCON, G. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. J. cardiovasc. Pharmacol. 25, 810-816 (1995).
5. BERTRIX, L., TIMOUR CHAH, Q., LANG, J., LAKHAL, M., BOUZOUITA, K. and FAUCON, G. Efficacy of disopyramide in comparison with verapamil and propranolol in the prevention of acetylcholine-induced atrial fibrillation in the dog. Arch. int. Pharmacodyn. 274, 97-110 (1985).
6. BROWNE, K. F., PRYSTOWSKY, E. N., ZIPES, D. P., CHILSON, D. A. and HEGER, J. J. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias. J. amer. Coll. Cardiol. 3, 357-364 (1984).
7. CAMPBELL, T. U. and VAUGHAN-WILLIAMS, E. M. Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiorasc. Res. 17, 251-258 (1983).
8. CARDIAC ARRHYTHMIA SUPPRESSION TRIAL (CAST) INVESTIGATORS. Mortality and morbidity in patients receiving encainide, flecainide or placebo. New Engl. J. Med. 324, 781-788 (1991).
9. CLUSIN, W. T., BUCHBINDER, M., ELLIS, A. K., KERNOFF, R. S., GIACOMINI, J. C. and HARRISON, D. C. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Circulat. Res. 54, 10-20 (1984).
10. CORABOEUF, E. Ionic basis of electrical activity in cardiac tissues. Amer. J. Physiol. 234, H101-H116 (1978).
11. DANISH VERAPAMIL INFARCTION TRIAL II (DAVIT II). Effect of verapamil on mortality and major events after acute myocardial infarction. Amer. J. Cardiol. 66, 779-785 (1990).
12. HEIJNIS, J. B., CORONEL, R. and VAN ZWIETEN, P. A. The effects of calcium antagonists on extracellular potassium accumulation during global ischemia in isolated perfused rat hearts. Cardiovasc. Drugs Ther. 5, 1035-1041 (1991).
13. HINE, L. K., LAIRD, N., HEWITT, P. and CHALMERS, T. C. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch. intern. Med. 149, 2694-2698 (1989).
14. JANSE, M. J. and WIT, A. L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69, 1049-1169 (1989).
15. KAUMANN, A. J. and ARAMENDIA, P. Prevention of ventricular fibrillation induced by coronary ligation. J. Pharmacol. exp. Ther. 164, 326-332 (1968).
16. KHALSA, A., OLSON, B. and HENRICKSSON, B. A. Effect of oral verapamil on ventricular irregularity in long-standing atrial fibrillation. Acta med. scand. 205, 39-47 (1979).
17. LYONS, C. J., BURGESS, M. J. and ABILDSKOV, J. A. Effects of acute hyperkalemia on cardiac excitability. Amer. Heart J. 94, 755-763 (1977).
18. MACMAHON, S., COLLINS, R., PETO, R., KOSTER, R. W. and YUSUF, S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from randomized, controlled trials. J. amer. med. Ass. 260, 1910-1916 (1988).
19. PATTERSON, E., GILSON, J. K. and LUCCHESI, B. R. Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic damage. Arrhythmogenic actions of lidocaine. J. cardiovasc. Pharmacol. 4, 925-934 (1982).
20. REUTER, H. Ion channels in cardiac cell membrane. Annu. Rev. Physiol. 46, 473-484 (1984).
21. SASSINE, A., MASSÉ, C., DUFOUR, A., HIRSCH, J. L., CAZES, M. and PUECH, P. Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog. Arch. int. Pharmacodyn. 269, 201-218 (1984).
22. STEENBERGEN, C., MURPHY, E., LEVY, L. and LONDON, R. E. Elevation in cytosolic free calcium concentration early in myocardial ischaemia in perfused rat heart. Circulat. Res. 60, 700-707 (1987).
23. SURAWICZ, B. Role of calcium-blocking agents in treatment of cardiac arrhythmia related to myocardial ischaemia. Amer. Heart J. 103, 698-706 (1982).
24. 2+ overload in reperfused ischemic myocardium. Annu. Rev. Physiol. 52, 543-559 (1990).
25. THANDROYEN, F. T. Protective action of calcium channel antagonist agents against ventricular fibrillation in the isolated perfused rat heart. J. molec. cell. Cordial. 14, 21-32 (1982).
26. TIMOUR, Q., AUPETIT, J. F., LOUFOUA-MOUNDANGA, J., GERENTES-CHASSAGNE, I., KIOUEH, I. and FAUCON, G. Class Ic antiarrhythmic drugs and myocardial ischaemia. Study in the pig heart in situ. Naunyn-Schmiedeberg's Arch. Pharmacol. 343, 645-651 (1991a).
27. TIMOUR, Q., LARBRE, J. P., AUPETIT, J. F., GERENTES-CHASSAGNE, I., LOUFOUA-MOUNDANGA, J., KIOUECH, I. and FAUCON, G. Protection against ischaemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart. Fund. clin. Pharmacol. 5, 641-644 (1991b).
28. TIMOUR, Q., LARBRE, J. P., KIOUEH, I., AUPETIT, J. F., LOUFOUA-MOUNDANGA, J., VIALLE, A. and FAUCON, G. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: Modification of cellular calcium overload. Arch. int. Pharmacodyn. 315, 30-46 (1992).
29. TIMOUR, Q., AUPETIT, J. F., CHEVREL, G., LOUFOUA-MOUNDANGA, J., OMAR, S. and FAUCON, G. Time course of electrical fibrillation threshold during brief periods of myocardial ischaemia and the genesis of fibrillation: Role of calcium. Cardiovasc. Drugs Ther. 8, 877-879 (1994).
30. TIMOUR CHAH, Q., BERTRIX, L., BOUZOUITA, K., LANG, J. and FAUCON, G. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ. Arch. int. Pharmacodyn. 261, 238-248 (1983).
31. VELEBIT, V., PODRID, P., LOWN, B., COHEN, B. H. and GRABOYS, T. B. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65, 886-895 (1982).
32. WEIDMANN, S. The effect of the cardiac membrane potential on the rapid availability of the sodium carrying system. J. Physiol., Lond. 127, 213-224 (1955).